Finance

Lists
002907:SHE
Chongqing Pharscin Pharmaceutical Co Ltd
CN¥14,67
-0,47%
(-0,070) 1D
13 Okt., 13:03:27 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002907...
Open
CN¥14,44
High
CN¥15,15
Low
CN¥14,29
Mkt. cap
6,45 mjd
Avg. vol.
15,31 m
Volume
7,53 m
Dividend
0,51%
Quarterly dividend
CN¥0,02
Ex-dividend date
04 Sep. 2026
P/E ratio
82,66
52-wk high
CN¥18,47
52-wk low
CN¥11,42
EPS
CN¥0,18
Shares outstanding
417,60 m
No. of employees
1 k
Open
CN¥14,44
High
CN¥15,15
Low
CN¥14,29
Mkt. cap
6,45 mjd
Avg. vol.
15,31 m
Volume
7,53 m
Dividend
0,51%
Quarterly dividend
CN¥0,02
Ex-dividend date
04 Sep. 2026
P/E ratio
82,66
52-wk high
CN¥18,47
52-wk low
CN¥11,42
EPS
CN¥0,18
Shares outstanding
417,60 m
No. of employees
1 k
News stories
From web sources and news partners
About Chongqing Pharscin Pharmaceutical Co Ltd
CEO-
Employees1,44 k
Founded04 Nov. 1996
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
184,00 m
201,23 m
211,85 m
201,70 m
Cost of goods sold
78,94 m
92,46 m
84,88 m
84,18 m
Cost of revenue
78,94 m
92,46 m
84,88 m
84,18 m
Research and development expenses
22,20 m
30,52 m
19,49 m
13,73 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,57 m
82,65 m
73,76 m
70,71 m
Operating expense
92,39 m
117,57 m
96,54 m
90,78 m
Total operating expenses
171,34 m
210,02 m
181,41 m
174,96 m
Operating income
12,66 m
-8,79 m
30,43 m
26,74 m
Other non operating income
-15,95 m
15,80 m
674,52 k
-711,55 k
EBT including unusual items
27,42 m
-12,09 m
37,60 m
30,20 m
EBT excluding unusual items
-1,67 m
-1,01 m
34,28 m
27,44 m
Income tax expense
11,79 m
618,10 k
8,69 m
3,15 m
Effective tax rate
43,00%
-5,11%
23,12%
10,43%
Other operating expenses
906,92 k
5,32 m
1,93 m
4,13 m
Net income
18,51 m
-7,37 m
32,79 m
30,19 m
Net profit margin
10,06%
-3,66%
15,48%
14,97%
Earnings per share
-
-
-
-
Interest and investment income
1,85 m
150,51 k
3,24 m
1,71 m
Interest expense
-238,82 k
-8,19 m
-70,53 k
-292,83 k
Net interest expenses
1,61 m
-8,03 m
3,17 m
1,41 m
Depreciation and amortization charges
-
-
-
-
EBITDA
33,92 m
12,63 m
51,86 m
50,50 m
Gain or loss from assets sale
-
-10,25 m
-
-
AI content may include mistakes. Learn more
Google-programme